# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Vernon Bernardino reiterates Cassava Sciences (NASDAQ:SAVA) with a Neutral.
Rodman & Renshaw analyst Elemer Piros reiterates Cassava Sciences (NASDAQ:SAVA) with a Buy and maintains $107 price target.